Background It is widely accepted that intellectual property legal requirements such as
patents and data exclusivity can affect access to medicines, but to date there has not been a …

We review the recent literature on financing biomedical innovation, with a specific focus on
the drug development process and how it may be enhanced to improve outcomes. We begin …

Observers worry that generic patent challenges are on the rise and reduce the effective
market life of drugs. A related concern is that challenges disproportionately target high-sales …

We estimate flight-level price elasticities using a database of online prices and seat map
displays. In contrast to market-level and route-level elasticities reported in the literature, flight …

Introduction Trends of prevalence, treatment, and control of hypertension have been
documented in the US, but changes in medical expenditures associated with hypertension …

Abstract Research Summary With the growth of digital platforms, understanding the role of
property rights on those platforms has become increasingly important. Digital piracy, the …

We review the literature on financial intermediation in the process by which new medical
therapeutics are financed, developed, and delivered. We discuss the contributing factors that …

Common ownership-where several firms are (partially) owned by the same investors-and its
impact on product market competition has recently drawn much attention. This paper …

This study investigates the impact of firm-specific uncertainty on innovation performance and
how alliances moderate this relationship in the pharmaceutical industry. To reflect drug …

Our study concentrates on the dynamic research and development (R&D) process in the
pharmaceutical industry, which is characterized by high uncertainty and a low probability of …